Cargando…

Ruthenium brachytherapy for iris melanoma

PURPOSE: The study aimed to review the long-term outcomes of ruthenium brachytherapy for iris and iridociliary melanoma. MATERIAL AND METHODS: Medical records of patients who underwent ruthenium plaque treatment for iris and iridociliary melanoma at the Department of Ophthalmology, Poznań University...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zwolin´ska, Emilia, Główka, Lidia, Chicheł, Adam, Rospond-Kubiak, Iwona
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2023
Materias:	Original Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669923/ https://www.ncbi.nlm.nih.gov/pubmed/38026074 http://dx.doi.org/10.5114/jcb.2023.132401

Ejemplares similares

Ruthenium brachytherapy for uveal melanoma – single institution experience
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2017)

Radiation retinopathy following episcleral brachytherapy for intraocular tumors: Current treatment options
por: Mularska, Weronika, et al.
Publicado: (2023)

Ruthenium brachytherapy for intraocular growth of a conjunctival squamous cell carcinoma: a case report
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2018)

Small-cell lung carcinoma metastasis to the iris – case presentation
por: Nikratowicz, Danuta, et al.
Publicado: (2013)

Brachytherapy and anterior segment imaging in iris melanoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017)

Brachytherapy and anterior segment imaging in iris melanoma
por: Song, Jin Soo Andy, et al.
Publicado: (2017)

Brachytherapy of Uveal Melanomas with Ruthenium-106 Plaques
por: Belaïd, Asma, et al.
Publicado: (2016)

Advanced non-melanoma skin cancer in elderly patients: When surgery says NO, interventional radiotherapy (brachytherapy) says YES
por: Chicheł, Adam, et al.
Publicado: (2023)

Brachytherapy in breast cancer: an effective alternative
por: Skowronek, Janusz, et al.
Publicado: (2014)

Retraction: Brachytherapy and anterior segment imaging in iris melanoma
Publicado: (2018)

Plaque brachytherapy in iris and iridociliary melanoma: a systematic review of efficacy and complications
por: Karimi, Saeed, et al.
Publicado: (2021)

Nomogram for predicting radiation maculopathy in patients treated with Ruthenium-106 plaque brachytherapy for uveal melanoma
por: Tagliaferri, Luca, et al.
Publicado: (2017)

Comparison of Iodide-125 and Ruthenium-106 Brachytherapy in the Treatment of Choroidal Melanomas
por: Ghassemi, Fariba, et al.
Publicado: (2020)

Ruthenium-106 brachytherapy for thick uveal melanoma: reappraisal of apex and base dose radiation and dose rate
por: Naseripour, Masood, et al.
Publicado: (2016)

Efficacy and complications of ruthenium-106 brachytherapy for uveal melanoma: a systematic review and meta-analysis
por: Karimi, Saeed, et al.
Publicado: (2021)

Long-Term Outcomes in Uveal Melanoma After Ruthenium-106 Brachytherapy
por: Cennamo, Gilda, et al.
Publicado: (2022)

The prevalence of various eyelid skin lesions in a single-centre observation study
por: Adamski, Wojciech Z., et al.
Publicado: (2020)

(106)Ruthenium eye plaque brachytherapy in the management of medium sized uveal melanoma
por: Jiang, Ping, et al.
Publicado: (2020)

High-dose-rate brachytherapy of primary cutaneous B-cell lymphoma: the first reported case series
por: Chyrek, Artur J., et al.
Publicado: (2020)

Reducing dysphagia with palliative 2D high-dose-rate brachytherapy improves survival in esophageal cancer
por: Burchardt, Wojciech, et al.
Publicado: (2019)

Primary uveal lymphoma effectively managed with oral chlorambucil: a case report
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2013)

HDR brachytherapy of prostate cancer – two years experience in Greater Poland Cancer Centre
por: Kanikowski, Marek, et al.
Publicado: (2009)

Vital role of volume and number of needles in HDR brachytherapy (HDR-BT) of prostate cancer
por: Chicheł, Adam, et al.
Publicado: (2009)

Cosmetic effect in patients with early breast cancer treated with breast conserving therapy (BCT) and with HDR brachytherapy (HDR-BT) “boost”
por: Kulik, Anna, et al.
Publicado: (2009)

Adjuvant interstitial three-dimensional pulse-dose-rate-brachytherapy for lip squamous cell carcinoma after surgical resection
por: Chyrek, Artur Jan, et al.
Publicado: (2019)

Outcome Analysis of Visual Acuity and Side Effect after Ruthenium-106 Plaque Brachytherapy for Medium-sized Choroidal Melanoma
por: AlMahmoud, Tahra, et al.
Publicado: (2018)

Tumor parameters predict the risk of side effects after ruthenium-106 plaque brachytherapy of uveal melanomas
por: Tarmann, Lisa, et al.
Publicado: (2017)

The potential of low-dose-rate brachytherapy with iodine-125 in the treatment of local recurrences of prostate cancer after primary high-dose-rate monotherapy
por: Burchardt, Wojciech M., et al.
Publicado: (2023)

Poststreptococcal syndrome mimicking conjunctival lymphoma
por: Rospond-Kubiak, Iwona, et al.
Publicado: (2013)

3D printing of individual skin brachytherapy applicator: design, manufacturing, and early clinical results
por: Bielęda, Grzegorz, et al.
Publicado: (2022)

HDR brachytherapy (HDR–BT) combined with stent placement in palliative treatment of esophageal cancer
por: Kanikowski, Marek, et al.
Publicado: (2009)

Ruthenium-106 Brachytherapy with or without Additional Local Therapy Shows Favorable Outcome for Variable-Sized Choroidal Melanomas in Korean Patients
por: Cho, Yeona, et al.
Publicado: (2018)

Anatomical and Functional Outcomes after Endoresection and Adjuvant Ruthenium Brachytherapy for Uveal Melanoma: A Single-Center Experience
por: Mazzini, Cinzia, et al.
Publicado: (2023)

Why is a very easy, useful, old technique underused? An overview of esophageal brachytherapy – interventional radiotherapy
por: Rovirosa, Ángeles, et al.
Publicado: (2022)

Iris extramedullary hematopoiesis in choroidal melanoma
por: Gallo, Beatrice, et al.
Publicado: (2020)

Optical coherence tomography angiography–based analysis of intrinsic vasculature in juxtapapillary melanoma after ruthenium-106 plaque brachytherapy
por: Shanmugam, P Mahesh, et al.
Publicado: (2019)

Complications and adverse events of plaque brachytherapy for ocular melanoma
por: Peddada, Krishi V., et al.
Publicado: (2019)

Superficial high-dose-rate brachytherapy for primary tumors and relapses after surgery in patients with basal cell carcinoma of the head and neck region: results of a retrospective comparative cohort study
por: Chyrek, Artur J., et al.
Publicado: (2022)

Unilateral acute iris transillumination syndrome with glaucoma and iris pigment epithelium dispersion simulating iris melanoma
por: Gonzalez Martinez, Orlando G., et al.
Publicado: (2023)

Correlation between treatment plan parameters and particular prognostic factors in prostate cancer treated with high–dose–rate brachytherapy (HDR–BT) as a boost
por: Chicheł, Adam, et al.
Publicado: (2009)

Cannot write session to /tmp/vufind_sessions/sess_k4n2lu6o1g5o9mjbplsh5kps9v